Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
CAMX.ST - Camurus AB
Q1 2025 Camurus AB Earnings Call
May 15, 2025 / 12:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
First quarter earnings score.
As previously, please note our forward-looking statements.
So the agenda for today's call is as follows. We start with business highlights followed by reviews of financial and commercial performance.
Then finish off with a short R&D update before moving over to Q&A.
So as previously with me today are John Garry, our Chief Financial Officer, and Richard Jason, Chief Commercial Officer.
So overall, Cameros had a productive and highly profitable first quarter of 2025.
This was driven by continuous commercial execution in Europe and Australia, strengthening our leadership position in opioid dependence treatment.
Vividol sales increased to 485 million,
Trustpilot
